Aztreonam lysine

氨曲南赖氨酸

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAztreonam lysine
Drug Alias NameAztreonam L-lysineAztreonam lysinateAitreonam lisinaAztreonamum LysinumCayston +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsLung DiseasesBronchiectasisCystic Fibrosis +[5] 
Global Approved IndicationsCystic Fibrosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2009/09/21
Country/TerritoryBelgiumCanadaUnited States +[20] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGilead Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences Ireland Uc
Inactive CompaniesGilead Sciences Inc
Active IndicationsCystic Fibrosis
Inactive IndicationsLung DiseasesBronchiectasisPseudomonas Infections +[4] 

Other Information

ATC CodeJ01DF01
Related LinksDrugBankKEGG